{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:27:53Z","timestamp":1771680473933,"version":"3.50.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Sarcoidosis is an immune mediated chronic inflammatory disorder that is best characterized by non-caseating granulomas found in one or more affected organs. The COVID-19 pandemic poses a challenge for clinicians caring for sarcoidosis patients who may be at increased risk of infection compared to the general population. With the recent availability of COVID-19 vaccines, it is expected that clinicians raise questions regarding efficacy and safety in sarcoidosis. However, studies examining safety and efficacy of vaccines in sarcoidosis are lacking. In this review, we examine the current literature regarding vaccination in immunocompromised populations and apply them to sarcoidosis patients. The available literature suggests that vaccines are safe and effective in patients with autoimmune disorders and in those taking immunosuppressive medications. We strongly recommend the administration of COVID-19 vaccines in patients with sarcoidosis. We also present a clinical decision algorithm to provide guidance on vaccination of sarcoidosis patients against COVID-19.<\/jats:p>","DOI":"10.3389\/fmed.2021.672028","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T04:27:41Z","timestamp":1619756861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities"],"prefix":"10.3389","volume":"8","author":[{"given":"Michael","family":"Manansala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Baughman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Novak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyse E.","family":"Lower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Korsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonder P.","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadera","family":"Sweiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11739-017-1778-6","article-title":"Sarcoidosis: a review for the internist","volume":"13","author":"Bargagli","year":"2018","journal-title":"Int Emerg Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1165\/rcmb.2002-0164PS","article-title":"Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex?","volume":"27","author":"Moller","year":"2002","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"Spagnolo","year":"2018","journal-title":"Lancet Respir Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e8846","DOI":"10.1097\/MD.0000000000008846","article-title":"Severe infections in sarcoidosis: incidence, predictors and long-term outcome in a cohort of 585 patients","volume":"96","author":"Dur\u00e9ault","year":"2017","journal-title":"Medicine."},{"key":"B5","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard2020"},{"key":"B6","doi-asserted-by":"publisher","first-page":"198114","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 vaccine: a comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"eabe0948","DOI":"10.1126\/scitranslmed.abe0948","article-title":"Prospects for a safe COVID-19 vaccine","volume":"12","author":"Haynes","year":"2020","journal-title":"Sci Transl Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19)","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA."},{"key":"B9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm' in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e2020009","DOI":"10.36141\/svdld.v37i4.10726","article-title":"Risk and outcome of COVID-19 infection in sarcoidosis patients: results of a self-reporting questionnaire","volume":"37","author":"Baughman","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"588527","DOI":"10.3389\/fmed.2020.588527","article-title":"Case series: COVID-19 in African American patients with sarcoidosis","volume":"7","author":"Manansala","year":"2020","journal-title":"Front Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s00408-020-00392-9","article-title":"Moderate or severe impairment in pulmonary function is associated with mortality in sarcoidosis patients infected with SARS-CoV-2","volume":"198","author":"Morgenthau","year":"2020","journal-title":"Lung."},{"key":"B14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 \u2014 COVID-NET, 14 States, March 1\u201330, 2020","volume":"69","author":"Garg","year":"2020","journal-title":"MMWR Morbidity and Mortality Weekly Report."},{"key":"B15","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.chest.2020.04.033","article-title":"When the game changes","volume":"158","author":"Sweiss","year":"2020","journal-title":"Chest."},{"key":"B16","first-page":"3","article-title":"Results of tetanus vaccination in sarcoidosis","volume":"29","author":"Seyhan","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1750-2659.2011.00290.x","article-title":"Influenza vaccination in patients with pulmonary sarcoidosis: efficacy and safety","volume":"6","author":"Tavana","year":"2012","journal-title":"Influenza Other Respir Viruses."},{"key":"B18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2147\/TCRM.S192922","article-title":"Refractory sarcoidosis: a review","volume":"16","author":"El Jammal","year":"2020","journal-title":"Ther Clin Risk Manag"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1080\/03007995.2017.1329140","article-title":"Is rheumatoid arthritis associated with reduced immunogenicity of the influenza vaccination? A systematic review and meta-analysis","volume":"33","author":"Huang","year":"2017","journal-title":"Curr Med Res Opin."},{"key":"B20","doi-asserted-by":"publisher","first-page":"R2","DOI":"10.1186\/ar4427","article-title":"Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis","volume":"16","author":"Kapetanovic","year":"2014","journal-title":"Arthrit Res Therapy."},{"key":"B21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/annrheumdis-2018-213222","article-title":"Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial","volume":"77","author":"Park","year":"2018","journal-title":"Ann Rheumat Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/ard.2007.077461","article-title":"Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response","volume":"67","author":"Oren","year":"2008","journal-title":"Ann Rheumat Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/art.25033","article-title":"Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab","volume":"62","author":"Van Assen","year":"2010","journal-title":"Arthrit Rheumat."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e001035","DOI":"10.1136\/rmdopen-2019-001035","article-title":"Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations","volume":"5","author":"Rondaan","year":"2019","journal-title":"RMD Open."},{"key":"B25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheumat Dis"},{"key":"B26","doi-asserted-by":"publisher","first-page":"87","DOI":"10.36141\/svdld.v37i2.9599","article-title":"Infection prevention in sarcoidosis: proposal for vaccination and prophylactic therapy","volume":"37","author":"Syed","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0140-6736(20)30607-3","article-title":"First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA","volume":"395","author":"Ghinai","year":"2020","journal-title":"Lancet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1056\/NEJMe2025111","article-title":"The covid-19 vaccine-development multiverse","volume":"383","author":"Heaton","year":"2020","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2020","journal-title":"N Engl J Med."},{"key":"B31","unstructured":"Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States2020"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/art.41734","article-title":"American College of Rheumatology Guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases - version 1","author":"Curtis","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1136\/gutjnl-2021-324388","article-title":"Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab","volume":"70","author":"Kennedy","year":"2021","journal-title":"Gut."},{"key":"B34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1183\/13993003.00430-2019","article-title":"Exome sequencing and pathogenicity-network analysis of five French families implicate mTOR signalling and autophagy in familial sarcoidosis","volume":"54","author":"Calender","year":"2019","journal-title":"Eur Respir J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-micro-020518-115759","article-title":"Human coronavirus: host-pathogen interaction","volume":"73","author":"Fung","year":"2019","journal-title":"Ann Rev Microbiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jtho.2020.02.010","article-title":"Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer","volume":"15","author":"Tian","year":"2020","journal-title":"J Thorac Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.it.2020.08.001","article-title":"Modeling potential autophagy pathways in covid-19 and sarcoidosis","volume":"41","author":"Calender","year":"2020","journal-title":"Trends Immunol."},{"key":"B39","unstructured":"StaffARL\n          The Color of Coronavirus: COVID-19 Deaths by Race and Ethnicity in the US2020"},{"key":"B40","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.vaccine.2020.12.069","article-title":"Black-white disparities in 2009 H1N1 vaccination among adults in the United States: a cautionary tale for the COVID-19 pandemic","volume":"39","author":"Burger","year":"2021","journal-title":"Vaccine."},{"key":"B41","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1016\/j.vaccine.2015.04.040","article-title":"Strategies for addressing vaccine hesitancy - a systematic review","volume":"33","author":"Jarrett","year":"2015","journal-title":"Vaccine."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.672028\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T04:27:46Z","timestamp":1619756866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.672028\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":41,"alternative-id":["10.3389\/fmed.2021.672028"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.672028","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"article-number":"672028"}}